Blog30 September 2024 Waiver of Consent vs Waiver of Written Consent One is very common, the other is rarely granted. Learn the key differences between waiver of consent & waiver of written consent for clinical trials Learn more
News12 August 2024 Castor Launches “Castor for Impact Program” to Advance Health Equity in Clinical Research Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech and Medical Device Companies Learn more
Success Stories23 July 2024 How MMI Leveraged Castor to Fulfill MDR Requirements for Their Groundbreaking Microsurgery Robot Castor provided MMI with a compliant, user-friendly platform that was able to enhance enrollment by over 500% and increase data returns for their PMCF study. Learn more
Success Stories11 July 2024 DTx company leverages Castor’s Real-World Evidence platform in Registry study How Castor’s eClinical system helped a DTx company to collect Real World Evidence for their behavioral disorder treatment Learn more
News8 February 2024 Castor collaborates with Microsoft to bring Practical AI to clinical trials. Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for patients & sites. Learn more
Blog26 September 2023 A Digital-First Mindset Shift on eConsent eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical and medical device companies remains a consideration for implementation teams. Learn more
Webinar Navigating successful eConsent adoption from sponsor to site Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent adoption from sponsor to site. Learn more
News21 August 2023 Castor announces Frans van Houten, former CEO of Philips, as the company’s new chairman of its Board Of Directors His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to Castor Learn more
Blog14 August 2023 Preparing Your eConsent Study for IRB Approval In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process. Learn more
News3 July 2023 Castor welcomes Jeanne Hecht to Board of Directors Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to its Board of Directors Learn more